Latest Insider Transactions at Assembly Biosciences, Inc. (ASMB)
This section provides a real-time view of insider transactions for Assembly Biosciences, Inc. (ASMB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ASSEMBLY BIOSCIENCES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ASSEMBLY BIOSCIENCES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 22
2023
|
Jason A Okazaki CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+20.81%
|
-
|
|
Mar 30
2023
|
John G Mc Hutchison |
SELL
Open market or private sale
|
Direct |
14,883
-7.73%
|
$0
$0.82 P/Share
|
|
Mar 30
2023
|
Jeanette M Bjorkquist Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
774
-3.15%
|
$0
$0.82 P/Share
|
|
Mar 30
2023
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
4,247
-4.15%
|
$0
$0.82 P/Share
|
|
Mar 30
2023
|
William E Iv Delaney Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,421
-3.85%
|
$0
$0.82 P/Share
|
|
Mar 29
2023
|
Jeanette M Bjorkquist Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+20.27%
|
-
|
|
Mar 27
2023
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
4,693
-4.38%
|
$4,693
$1.02 P/Share
|
|
Feb 16
2023
|
William E Iv Delaney Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+10.11%
|
-
|
|
Feb 16
2023
|
Jason A Okazaki CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+10.45%
|
-
|
|
Aug 08
2022
|
John G Mc Hutchison |
SELL
Open market or private sale
|
Direct |
12,314
-6.01%
|
$24,628
$2.13 P/Share
|
|
Jul 25
2022
|
Michael P. Samar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,020
-2.55%
|
$4,040
$2.22 P/Share
|
|
May 31
2022
|
William E Iv Delaney Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,164
-5.17%
|
$4,164
$1.92 P/Share
|
|
Mar 30
2022
|
John G Mc Hutchison |
SELL
Open market or private sale
|
Direct |
4,614
-2.2%
|
$9,228
$2.17 P/Share
|
|
Mar 30
2022
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
1,269
-1.32%
|
$2,538
$2.17 P/Share
|
|
Mar 30
2022
|
William E Iv Delaney Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,038
-1.31%
|
$2,076
$2.17 P/Share
|
|
Mar 30
2022
|
Luisa M Stamm Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,038
-2.51%
|
$2,076
$2.17 P/Share
|
|
Mar 30
2022
|
Michael P. Samar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,285
-2.89%
|
$4,570
$2.17 P/Share
|
|
Mar 29
2022
|
John G Mc Hutchison |
BUY
Grant, award, or other acquisition
|
Direct |
83,750
+28.56%
|
-
|
|
Mar 29
2022
|
Jason A Okazaki CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+24.58%
|
-
|
|
Mar 29
2022
|
William E Iv Delaney Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+24.01%
|
-
|
|
Mar 29
2022
|
Luisa M Stamm Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+35.24%
|
-
|
|
Mar 29
2022
|
Michael P. Samar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+24.93%
|
-
|
|
Mar 28
2022
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
4,617
-6.67%
|
$9,234
$2.24 P/Share
|
|
Aug 09
2021
|
John G Mc Hutchison |
SELL
Open market or private sale
|
Direct |
12,156
-8.82%
|
$36,468
$3.6 P/Share
|
|
Jul 22
2021
|
Michael P. Samar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,938
+17.44%
|
-
|
|
May 27
2021
|
William E Iv Delaney Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,129
-7.21%
|
$16,516
$4.03 P/Share
|
|
Mar 29
2021
|
Jason A Okazaki CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
13,750
+16.98%
|
-
|
|
Mar 29
2021
|
Thomas Joseph Russo CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,250
+17.08%
|
-
|
|
Mar 29
2021
|
Luisa M Stamm Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,250
+37.37%
|
-
|
|
Mar 29
2021
|
William E Iv Delaney Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,250
+16.67%
|
-
|
|
Dec 14
2020
|
Jacqueline Sybil Papkoff SVP-CSO Microbiome |
SELL
Open market or private sale
|
Direct |
1,297
-3.35%
|
$7,782
$6.15 P/Share
|
|
Nov 09
2020
|
Luisa M Stamm Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,397
-36.64%
|
$21,985
$5.1 P/Share
|